NicOx appoints Philippe Masquida as evp, md of European operations

Next step in strategy to create international ophthalmology company

NicOx has appointed Philippe Masquida as executive vice president, managing director of European Operations. He has more than 22 years of international pharmaceutical experience and a track record in ophthalmology.

As well as leading NicOx’s operations in Europe, Masquida will be responsible, in coordination with NicOx’s executive team, for identifying and evaluating commercial opportunities in Europe as part of the company’s strategy to build a late-stage ophthalmic portfolio.

Masquida joins NicOx from Pierre Fabre, where he was vice president, Head of International Operations, Pharmaceuticals. Prior to this he spent seven years at Allergan. He also held the position of director of International Affairs for eight years at Laboratoires Théa. He has previously held a number of positions at Sanofi Aventis (Fisons) and Merck Inc.

NicOx has also recently appointed Jerry St Peter in the US as part of its strategy to build an ophthalmic portfolio.

You may also like

Finance

NicOx takes 12% stake in Altacor

Broadening its position in the ophthalmology sector
Packaging

How pharma packaging manufacturers role is evolving: the case of extractables testing

As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality and safety, ensuring one of the key functions pharma containers are designed for, says Anna Malori, Head of Product Management at Bormioli Pharma
Regulatory

Merck's Welireg approved for cancers associated with von Hippel-Lindau disease in China

The once-daily drug is the first HIF-2α to be approved in China, exhibiting a 49% objective response rate (ORR)
Manufacturing

Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company

The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
Packaging

Dual-chamber packaging systems as a simplification factor in the supply chain

Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma
Regulatory

Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi

The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format
Regulatory

Syndax Pharmaceuticals' leukaemia drug Revuforj bags FDA approval

The therapeutic is the first and only menin inhibitor to gain FDA approval for acute relapsed or refractory acute leukaemia
Subscribe now